TY - JOUR TI - Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study AU - Ami D. Sperber AU - Shrikant I. Bangdiwala AU - Douglas A. Drossman AU - Uday C. Ghoshal AU - Magnus Simrén AU - Jan Tack AU - William E. Whitehead AU - Dan L. Dumitraşcu AU - Xuicai Fang AU - Shin Fukudo AU - John Kellow AU - Edith Okeke AU - Eamonn M.M. Quigley AU - Max J. Schmulson AU - Peter J. Whorwell AU - Timothy Archampong AU - Payman Adibi AU - Viola Andresen AU - Marc A. Benninga AU - Bruno Bonaz AU - Serhat Bor AU - Luis Bustos Fernández AU - Suck Chei Choi AU - Enrico Corazziari AU - Carlos Fernando de Magalhães Francisconi AU - Albis Hani AU - Л. Б. Лазебник AU - Yeong Yeh Lee AU - Agata Mulak AU - M. Masudur Rahman AU - Javier Santos AU - Mashiko Setshedi AU - Ari Fahrial Syam AU - Stephen Vanner AU - Reuben K. Wong AU - Aurelio López‐Colombo AU - Valeria Atenea Costa AU - Ram Dickman AU - Motoyori Kanazawa AU - Ammar Hassanzadeh Keshteli AU - Rutaba Khatun AU - Iradj Maleki AU - Pierre Poitras AU - Nitesh Pratap AU - O. V. Stefanyuk AU - S R Thomson AU - Judith Zeevenhooven AU - Olafur S. Palsson PY - 2020 JO - Gastroenterology DO - 10.1053/j.gastro.2020.04.014 UR - https://doi.org/10.1053/j.gastro.2020.04.014 AB - BACKGROUND & AIMS: Although functional gastrointestinal disorders (FGIDs), now called disorders of gut-brain interaction, have major economic effects on health care systems and adversely affect quality of life, little is known about their global prevalence and distribution. We investigated the prevalence of and factors associated with 22 FGIDs, in 33 countries on 6 continents. METHODS: Data were collected via the Internet in 24 countries, personal interviews in 7 countries, and both in 2 countries, using the Rome IV diagnostic questionnaire, Rome III irritable bowel syndrome questions, and 80 items to identify variables associated with FGIDs. Data collection methods differed for Internet and household groups, so data analyses were conducted and reported separately. RESULTS: Among the 73,076 adult respondents (49.5% women), diagnostic criteria were met for at least 1 FGID by 40.3% persons who completed the Internet surveys (95% confidence interval [CI], 39.9-40.7) and 20.7% of persons who completed the household surveys (95% CI, 20.2-21.3). FGIDs were more prevalent among women than men, based on responses to the Internet survey (odds ratio, 1.7; 95% CI, 1.6-1.7) and household survey (odds ratio, 1.3; 95% CI, 1.3-1.4). FGIDs were associated with lower quality of life and more frequent doctor visits. Proportions of subjects with irritable bowel syndrome were lower when the Rome IV criteria were used, compared with the Rome III criteria, in the Internet survey (4.1% vs 10.1%) and household survey (1.5% vs 3.5%). CONCLUSIONS: In a large-scale multinational study, we found that more than 40% of persons worldwide have FGIDs, which affect quality of life and health care use. Although the absolute prevalence was higher among Internet respondents, similar trends and relative distributions were found in people who completed Internet vs personal interviews. ER -